Neocor Therapeutics
PrivateLast Round
Grant
Oct 15, 2025
Total Funding Raised
$940,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neocor Therapeutics operates in Healthcare & Life Sciences and is based in La Ciotat. Its latest recorded funding round was a Grant round in October 2025.
Neocor Therapeutics is a biotechnology company that is developing a novel gene therapy approach for cardiac diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neocor Therapeutics Comparables
Compare Neocor Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BiVACOR | 82% | |
| Picard Medical, Inc. | 78% | |
| Carmat | 75% |
For institutional investors. Book with your work email.
Neocor Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 15, 2025 | ||||
| Grant | Jan 1, 2024 | ||||
| Pre Seed | Dec 1, 2023 |
For institutional investors. Book with your work email.
Neocor Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SATT Sud-Est | Grant |
| Bpifrance | Grant |
| Crédit Agricole Alpes Provence | Pre Seed |
| Incubateur Impulse | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2025
$431K grant received from Bpifrance.
- Jan 1, 2024
$437K grant received from SATT Sud-Est.
For institutional investors. Book with your work email.
Neocor Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neocor Therapeutics's valuation, stock price, and market status.
Is Neocor Therapeutics a public or private company?
Neocor Therapeutics is a private company.
What is the current stock price of Neocor Therapeutics?
Neocor Therapeutics is a private company, so its shares have no public market price. Caplight tracks Neocor Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neocor Therapeutics worth (valuation)?
Valuation information for Neocor Therapeutics is not publicly available.
Can I buy Neocor Therapeutics stock?
Neocor Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neocor Therapeutics's last funding round?
Neocor Therapeutics's most recent funding round was Grant on October 15, 2025.
Who are the main investors in Neocor Therapeutics?
Key investors in Neocor Therapeutics include SATT Sud-Est, Bpifrance, Crédit Agricole Alpes Provence, Incubateur Impulse.
Will Neocor Therapeutics IPO soon?
No public IPO plans have been announced for Neocor Therapeutics.
How can I track Neocor Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Neocor Therapeutics's shares on secondary markets.